Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma: the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study
Nom du journal : Br J Cancer
Année : 2011
Volume : 104
Page de départ : 1544
Page de fin : 1550